Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.
Deng
Kai
K
Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Adams
Michelle M
MM
Damani
Payal
P
Livingston
Philip O
PO
Ragupathi
Govind
G
Gin
David Y
DY
D000276:Adjuvants, Immunologic / Q000138:chemical synthesis / Q000737:chemistry; D000577:Amides / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D019496:Cancer Vaccines / Q000276:immunology*; D005260:Female; D005732:Gangliosides / Q000276:immunology; D008546:Melanoma, Experimental / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D012503:Saponins / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000577:Amides; D019496:Cancer Vaccines; D005732:Gangliosides; C531367:QS-21-xylose; D012503:Saponins; C069132:ganglioside GD3 amide congener; C078785:saponin QA-21V1